期刊文献+

酮洛芬巴布剂的研制及体外透皮研究 被引量:8

Preparation of ketoprofen cataplasm and research on its skin penetration in vitro
下载PDF
导出
摘要 目的:研制酮洛芬巴布剂并研究其体外释药性能和经皮吸收特点。方法:以水溶性高分子材料为辅料制备酮洛芬巴布剂,用HPLC法测定酮洛芬的经皮吸收量,按《中华人民共和国药典》2005年版方法进行体外释放度测定,利用改良Franz扩散池研究巴布剂的经皮吸收特点。结果:酮洛芬巴布剂含膏量均匀,含量稳定,体外释药符合Weibull分布方程。巴布剂中的酮洛芬24 h内以零级动力学经皮渗透,体外经皮释药方程为Q=10.196 t-7.954 7(r=0.998 8),24 h累积渗透量为244.70μg/cm2。结论:酮洛芬巴布剂为一种新型控释型经皮给药制剂。 Objective: To study the preparation of ketoprofen cataplasm and its characteristics of release in vitro. Methods: Ketoprofen cataplasm was prepared with some macromolecular water-soluble materials as base. The content of ketoprofen was determined by HPLC method. Its release test in vitro was carried out according to the method of Chinese Pharmacopoeia 2005 edition. The BLAB/c mouse skin penetration test in vitro was performed by modified Franz diffusion cell. Results: The ketoprofen cataplasm was homogeneous and had constant content of ketoprofen. Its release property in vitro conformed to Weibull equation. The penetration of ketoprofen in the cataplasm through the BLAB/c mouse skin followed zeroorder dynamics in 24 h. Its release equation in vitro was Q= 10. 196 t- 7. 954 7 (r=0. 998 8). The cumulative permeation quantity in 24 h was 244.70 μg/cm^2 through BLAB/c mouse skin in vitro. Conclusion: The ketoprofen cataplasm is a new transdermal agent of sustained release property.
出处 《药学服务与研究》 CAS CSCD 2006年第5期338-341,共4页 Pharmaceutical Care and Research
基金 国家自然科学基金资助项目(No.30572269)
关键词 酮洛芬 巴布剂 投药 皮肤 体外释放 透皮 ketoprofen cataplasm administration,cutaneous in vitro release skin penetration
  • 相关文献

参考文献7

二级参考文献17

  • 1陈幼亭.溶出度试验数学模型及计算机程序[J].医药工业,1988(2):66-72. 被引量:8
  • 2于香安,蔡怀友.用电子计算器求算片剂溶出度溶出参数的运算程序[J].中国药房,1995,6(4):21-22. 被引量:102
  • 3彭永富,董慧.药物溶出度Weibul分布的计算机求解[J].中国药学杂志,1996,31(10):606-608. 被引量:58
  • 4Sloan KB, Wasdo S. Designing for topical delivery:prodrugs can make the difference [ J ]. Med Res Rev,2003,23 (6) :763 - 793. 被引量:1
  • 5Redinbo MR, Bencharit S, Potter PM. Human carboxylesterase 1: from drug metabolism to drug discovery [J]. Biochem Soc Trans, 2003,31(3):620-624. 被引量:1
  • 6Afouna MI, Fincher TK, Khan MA, et al. Percutaneous permeation of enantiomers and racemates of chiral drugs and prediction of their flux ratios using thermal data: a pharmaceutical perspective [ J ]. Chirality, 2003, 15(5) :456 -465. 被引量:1
  • 7Humerickhouse R, Lohrbach K, Li L, et al.Characterization of CPT-11 hydrolysis by human liver carboxylesterase isoforms hCE-1 and hCE-2 [J]. Cancer Res, 2000,60(5) :1189 - 1192. 被引量:1
  • 8ZengLG GongSX XiaZN.HPLC determination of dexketoprofen [J].药物分析杂志,2002,22(1):74-74. 被引量:1
  • 9JinDY LiMF.分克隆实验指南 [M]: 2nd Ed[M].Beijing:Science Press,1993.304-366. 被引量:1
  • 10Friedberg T. Molecular biological methods for characterizing drug-metabolizing enzymes in hepatic and extrahepatic tissues [ J ]. Skin Pharmcol Appl Physiol,1998,11(1) :61-69. 被引量:1

共引文献206

同被引文献73

引证文献8

二级引证文献40

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部